title: JAK2 V617F, hemostatic polymorphisms, and clinical features as risk factors for arterial thrombotic events in essential thrombocythemia.
authors: María J
authors: MJ
authors: Moreno
authors: María L
authors: ML
authors: Lozano
authors: V
authors: V
authors: Roldán
authors: B
authors: B
authors: Bellosillo
authors: N
authors: N
authors: García-Barberá
authors: J
authors: J
authors: Rivera
authors: L
authors: L
authors: Navarro-Núñez
authors: C
authors: C
authors: Besses
authors: V
authors: V
authors: Vicente
authors: C
authors: C
authors: Martínez
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019943:Amino Acid Substitution; D005260:Female; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D012307:Risk Factors; D013920:Thrombocythemia, Essential / Q000235:genetics*; D013927:Thrombosis / Q000150:complications / Q000235:genetics*
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2